Vidmantas Petraitis

Vidmantas Petraitis publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Vidmantas Petraitis sits on this spectrum.

Vidmantas Petraitis D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Vidmantas Petraitis sits on this spectrum.

Best Publications

• Comparative Efficacy and Distribution of Lipid Formulations of Amphotericin B in Experimental Candida albicans Infection of the Central Nervous System

  Andreas H. Groll;Neelam Giri;Vidmantas Petraitis;Ruta Petraitiene

  426
  Citations

• Experimental Pulmonary Aspergillosis Due to Aspergillus terreus: Pathogenesis and Treatment of an Emerging Fungal Pathogen Resistant to Amphotericin B

  Thomas J. Walsh;Vidmantas Petraitis;Ruta Petraitiene;Aida Field-Ridley

  353
  Citations

• Combination Therapy in Treatment of Experimental Pulmonary Aspergillosis: Synergistic Interaction between an Antifungal Triazole and an Echinocandin

  Vidmantas Petraitis;Ruta Petraitiene;Alia A Sarafandi;Amy M Kelaher

  323
  Citations

• Antifungal Efficacy of Caspofungin (MK-0991) in Experimental Pulmonary Aspergillosis in Persistently Neutropenic Rabbits: Pharmacokinetics, Drug Disposition, and Relationship to Galactomannan Antigenemia

  Ruta Petraitiene;Vidmantas Petraitis;Andreas H. Groll;Tin Sein

  258
  Citations

• Antifungal Activity and Pharmacokinetics of Posaconazole (SCH 56592) in Treatment and Prevention of Experimental Invasive Pulmonary Aspergillosis: Correlation with Galactomannan Antigenemia

  Ruta Petraitiene;Vidmantas Petraitis;Andreas H. Groll;Tin Sein

  249
  Citations

• Comparative Antifungal Activities and Plasma Pharmacokinetics of Micafungin (FK463) against Disseminated Candidiasis and Invasive Pulmonary Aspergillosis in Persistently Neutropenic Rabbits

  Vidmantas Petraitis;Ruta Petraitiene;Andreas H. Groll;Kristin Roussillon

  240
  Citations

• The Pharmacokinetics and Pharmacodynamics of Micafungin in Experimental Hematogenous Candida Meningoencephalitis: Implications for Echinocandin Therapy in Neonates

  William W. Hope;Diana Mickiene;Diana Mickiene;Vidmantas Petraitis;Vidmantas Petraitis;Ruta Petraitiene;Ruta Petraitiene

  225
  Citations

• Detection of Galactomannan Antigenemia in Patients Receiving Piperacillin-Tazobactam and Correlations between In Vitro, In Vivo, and Clinical Properties of the Drug-Antigen Interaction

  Thomas J. Walsh;Shmuel Shoham;Ruta Petraitiene;Tin Sein

  200
  Citations

• Pharmacokinetic and Pharmacodynamic Modeling of Anidulafungin (LY303366): Reappraisal of Its Efficacy in Neutropenic Animal Models of Opportunistic Mycoses Using Optimal Plasma Sampling

  Andreas H. Groll;Diana Mickiene;Ruta Petraitiene;Vidmantas Petraitis

  188
  Citations

• Pathogenesis of Aspergillus fumigatus and the Kinetics of Galactomannan in an In Vitro Model of Early Invasive Pulmonary Aspergillosis: Implications for Antifungal Therapy

  William W. Hope;Michael J. Kruhlak;Caron A. Lyman;Ruta Petraitiene

  176
  Citations

• Compartmental Pharmacokinetics and Tissue Distribution of the Antifungal Echinocandin Lipopeptide Micafungin (FK463) in Rabbits

  Andreas H. Groll;Diana Mickiene;Vidmantas Petraitis;Ruta Petraitiene

  175
  Citations

• Detection of a Molecular Biomarker for Zygomycetes by Quantitative PCR Assays of Plasma, Bronchoalveolar Lavage, and Lung Tissue in a Rabbit Model of Experimental Pulmonary Zygomycosis

  Miki Kasai;Susan M. Harrington;Susan M. Harrington;Andrea Francesconi;Vidmantas Petraitis;Vidmantas Petraitis

  168
  Citations

• Antifungal Efficacy, Safety, and Single-Dose Pharmacokinetics of LY303366, a Novel Echinocandin B, in Experimental Pulmonary Aspergillosis in Persistently Neutropenic Rabbits

  Vidmantas Petraitis;Ruta Petraitiene;Andreas H. Groll;Aaron Bell

  167
  Citations

• Antifungal Activity of LY303366, a Novel Echinocandin B, in Experimental Disseminated Candidiasis in Rabbits

  Ruta Petraitiene;Vidmantas Petraitis;Andreas H. Groll;Myrna Candelario

  150
  Citations

• In vitro interactions between farnesol and fluconazole, amphotericin B or micafungin against Candida albicans biofilms

  Aspasia Katragkou;Matthew McCarthy;Elizabeth L. Alexander;Charalampos Antachopoulos

  133
  Citations

• Combination Therapy in Treatment of Experimental Pulmonary Aspergillosis: In Vitro and In Vivo Correlations of the Concentration- and Dose- Dependent Interactions between Anidulafungin and Voriconazole by Bliss Independence Drug Interaction Analysis

  Vidmantas Petraitis;Ruta Petraitiene;William W. Hope;Joseph Meletiadis

  125
  Citations

• Echinocandins: The Expanding Antifungal Armamentarium

  Unknown

  119
  Citations

• Triazole-Polyene Antagonism in Experimental Invasive Pulmonary Aspergillosis: In Vitro and In Vivo Correlation

  Joseph Meletiadis;Vidmantas Petraitis;Ruta Petraitiene;Pengxin Lin

  117
  Citations

• Characterization and Comparison of Galactomannan Enzyme Immunoassay and Quantitative Real-Time PCR Assay for Detection of Aspergillus fumigatus in Bronchoalveolar Lavage Fluid from Experimental Invasive Pulmonary Aspergillosis

  Andrea Francesconi;Miki Kasai;Ruta Petraitiene;Ruta Petraitiene;Vidmantas Petraitis;Vidmantas Petraitis

  112
  Citations

• Development and Validation of a Quantitative Real-Time PCR Assay Using Fluorescence Resonance Energy Transfer Technology for Detection of Aspergillus fumigatus in Experimental Invasive Pulmonary Aspergillosis

  Cathal E. O'Sullivan;Miki Kasai;Andrea Francesconi;Vidmantas Petraitis

  110
  Citations